TACROLIMUS | A090596 | MYLAN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.6880
per ea
Lowest NADAC/Unit
$0.1192
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 51079002820TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) | $0.6880 | EA | Generic | — | 2026-10-21 |
| 00378204701TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) | $0.6880 | EA | Generic | — | 2026-10-21 |
| 00378204601TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) | $0.1598 | EA | Generic | — | 2026-10-21 |
| 51079081820TACROLIMUS 1 MG CAPSULE (IMMEDIATE RELEASE) | $0.1598 | EA | Generic | — | 2026-10-21 |
| 00378204501TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) | $0.1192 | EA | Generic | — | 2026-10-21 |
| 51079081720TACROLIMUS 0.5 MG CAPSULE (IMMEDIATE RELEASE) | $0.1192 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.